3-Fluoro-4-[4-[2-(3,5-dimethylphenyl)pyrrolidin-1-ylmethyl]phenoxy]benzamide of structural formula depicted herein and a pharmaceutically acceptable salt thereof is disclosed. This compound is suitable for use in the treatment of: (a) an anxiety disorder selected from panic disorder, obsessive-compulsive disorder, social phobia, generalized anxiety disorder, specific phobia, and posttraumatic stress disorder or (b) a depressive illness selected from major depression, dysthymia and bipolar disorder or (c) an anxiety disorder selected from (a) and a depressive illness selected from b) or (d) ethanol use disorder and an anxiety disorder selected from a) or (e) ethanol use disorder and a depressive illness selected from (b) or (f) ethanol use disorder and an anxiety disorder selected from (a) and a depressive illness selected from (b) or (g) schizophrenia or (h) ethanol use disorder and schizophrenia
